VanEck Biotech ETF (BBHCL)

Overview

This fund is designed for investors seeking exposure to the U.S. biotechnology sector. It mainly focuses on investing in securities (such as common stocks and depositary receipts) that are part of its benchmark Biotech Index. The index includes companies within the biotechnology industry that are listed on U.S. exchanges. It targets not only large-cap companies but also gives room to medium-capitalization and foreign companies that have chosen to list in the U.S. Despite its exposure to a broad range of companies within the biotech sector, the fund is non-diversified, meaning it may invest more heavily in individual securities than a diversified fund would.

Products and Services

• Securities of the Biotech Index

The fund primarily invests in securities that make up the Biotech Index. This includes a selection of common stocks and depositary receipts from companies involved in the biotechnology sector, providing investors with focused exposure to biotech advancements and innovations.

• Investments in Medium-Cap Companies

Aside from large-cap companies, the fund extends its investments to include medium-capitalization companies within the biotechnology industry. This offers a blend of growth potential and stability, tapping into the dynamic nature of smaller companies that are poised for growth.

• Access to Foreign Companies Listed on U.S. Exchanges

Recognizing the global scope of the biotechnology industry, the fund also includes foreign companies that are listed on U.S. exchanges. This allows investors to gain exposure to international players in the biotech field without the complexities of investing directly in foreign markets.